Literature DB >> 9806800

MPF amplification in Xenopus oocyte extracts depends on a two-step activation of cdc25 phosphatase.

A Karaïskou1, X Cayla, O Haccard, C Jessus, R Ozon.   

Abstract

The activation of Cdc2 kinase induces the entry into M-phase of all eukaryotic cells. We have developed a cell-free system prepared from prophase-arrested Xenopus oocytes to analyze the mechanism initiating the all-or-none activation of Cdc2 kinase. Inhibition of phosphatase 2A, the major okadaic acid-sensitive Ser/Thr phosphatase, in these extracts, provokes Cdc2 kinase amplification and concomitant hyperphosphorylation of Cdc25 phosphatase, with a lag of about 1 h. Polo-like kinase (Plx1 kinase) is activated slightly after Cdc2. All these events are totally inhibited by the cdk inhibitor p21(Cip1), demonstrating that Plx1 kinase activation depends on Cdc2 kinase activity. Addition of a threshold level of recombinant Cdc25 induces a linear activation of Cdc2 and Plx1 kinases and a partial phosphorylation of Cdc25. We propose that the Cdc2 positive feedback loop involves two successive phosphorylation steps of Cdc25 phosphatase: the first one is catalyzed by Cdc2 kinase and/or Plx1 kinase but it does not modify Cdc25 enzymatic activity, the second one requires a new kinase counteracted by phosphatase 2A. Furthermore we demonstrate that, under our conditions, Cdc2 amplification and MAP kinase activation are two independent events. Copyright 1998 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9806800     DOI: 10.1006/excr.1998.4220

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  18 in total

1.  A novel p34(cdc2)-binding and activating protein that is necessary and sufficient to trigger G(2)/M progression in Xenopus oocytes.

Authors:  I Ferby; M Blazquez; A Palmer; R Eritja; A R Nebreda
Journal:  Genes Dev       Date:  1999-08-15       Impact factor: 11.361

Review 2.  Triggering the all-or-nothing switch into mitosis.

Authors:  P H O'Farrell
Journal:  Trends Cell Biol       Date:  2001-12       Impact factor: 20.808

3.  Direct roles of the signaling kinase RSK2 in Cdc25C activation during Xenopus oocyte maturation.

Authors:  Ruoning Wang; Sung Yun Jung; Chuan Fen Wu; Jun Qin; Ryuji Kobayashi; Gary E Gallick; Jian Kuang
Journal:  Proc Natl Acad Sci U S A       Date:  2010-11-01       Impact factor: 11.205

Review 4.  14-3-3 proteins as signaling integration points for cell cycle control and apoptosis.

Authors:  Alexandra K Gardino; Michael B Yaffe
Journal:  Semin Cell Dev Biol       Date:  2011-09-14       Impact factor: 7.727

5.  CCT chaperonin complex is required for the biogenesis of functional Plk1.

Authors:  Xiaoqi Liu; Chin-Yo Lin; Ming Lei; Shi Yan; Tianhua Zhou; Raymond L Erikson
Journal:  Mol Cell Biol       Date:  2005-06       Impact factor: 4.272

6.  A p90(rsk) mutant constitutively interacting with MAP kinase uncouples MAP kinase from p34(cdc2)/cyclin B activation in Xenopus oocytes.

Authors:  A C Gavin; A Ni Ainle; E Chierici; M Jones; A R Nebreda
Journal:  Mol Biol Cell       Date:  1999-09       Impact factor: 4.138

7.  PP1 control of M phase entry exerted through 14-3-3-regulated Cdc25 dephosphorylation.

Authors:  Seth S Margolis; Susan Walsh; Douglas C Weiser; Minoru Yoshida; Shirish Shenolikar; Sally Kornbluth
Journal:  EMBO J       Date:  2003-11-03       Impact factor: 11.598

8.  Activation of Cdc2/cyclin B and inhibition of centrosome amplification in cells depleted of Plk1 by siRNA.

Authors:  Xiaoqi Liu; Raymond L Erikson
Journal:  Proc Natl Acad Sci U S A       Date:  2002-06-19       Impact factor: 11.205

9.  A role for PP1 in the Cdc2/Cyclin B-mediated positive feedback activation of Cdc25.

Authors:  Seth S Margolis; Jennifer A Perry; Douglas H Weitzel; Christopher D Freel; Minoru Yoshida; Timothy A Haystead; Sally Kornbluth
Journal:  Mol Biol Cell       Date:  2006-02-08       Impact factor: 4.138

10.  Distinct regulators for Plk1 activation in starfish meiotic and early embryonic cycles.

Authors:  Takayuki Okano-Uchida; Eiichi Okumura; Motoko Iwashita; Hitoshi Yoshida; Kazunori Tachibana; Takeo Kishimoto
Journal:  EMBO J       Date:  2003-10-15       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.